• Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Buy" from Brokerages

    Source: Buzz FX / 23 Nov 2024 05:09:09   America/Chicago


    Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Buy" from Brokerages Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of Keros Therapeutics, Inc. ( NASDAQ:KROS - Get Free Report ) have been
    Read more...
Share on,